THE TBI EVALUATION STATION
DEAD

Serial Number

98379682

Owner

BRAINBOX SOLUTIONS, INC.

Attorney

Leesa N. Weiss

Filing Date

Jan 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

THE TBI EVALUATION STATION Trademark

Serial Number: 98379682

THE TBI EVALUATION STATION is a trademark filed by BRAINBOX SOLUTIONS, INC. on January 29, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BRAINBOX SOLUTIONS, INC. (6 trademarks)

RICHMOND, VA 23219

Entity Type: 03

Trademark Details

Filing Date

January 29, 2024

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

Medical testing and assessment services, for the testing, evaluation, analysis and reporting of patient results associated with brain and head trauma and injury from multi-modalities for diagnostic and medical testing purposes

Computer hardware; downloadable software and downloadable mobile applications for use in the diagnosis, prognosis, and monitoring of brain and head trauma and injury through the analysis of diagnostic reagents; downloadable software and downloadable mobile applications for assessing physiologic measures, performing behavioral, cognitive, psychological, vestibular and ocular motility based neuro-diagnostic tests, for accessing data, reports, and summaries of patient autonomic nervous system testing, and for reporting a combined multi-modality score for the diagnosis, prognosis and monitoring of brain and head trauma and injury

Medical testing devices for measuring disease markers, in the fields of immunoassays, and molecular diagnostics, including the use of an assay test panel, composed of one or more brain-enriched biomarkers, and for measuring blood flow and imaging for the purposes of identifying, testing for, detecting, monitoring, and reporting on brain and head trauma and injury

Clinical and in vitro diagnostic reagents for medical use; Clinical and in vitro diagnostic reagents for medical use, namely, immunoassay test kits, consisting primarily of in vitro reagents for the diagnosis, prognosis, and monitoring of conditions of physiological significance; Clinical and in vitro diagnostic reagents for medical diagnostic assay kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids, for medical diagnosis; Medical diagnostic assay test kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 29, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 19, 2025 EX1G
SOU EXTENSION 1 FILED
May 19, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 19, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2024 NWOS
NEW APPLICATION ENTERED
Jan 29, 2024 NWAP